Evidence map›Paper›PMID 34377425›Full record

ArticleChemical science2021

Total synthesis of (+)-spiroindimicin A and congeners unveils their antiparasitic activity.

Zhen Zhang, Sneha Ray, Leah Imlay, Lauren T Callaghan, Hanspeter Niederstrasser, Prema Latha Mallipeddi, Bruce A Posner, Dawn M Wetzel, Margaret A Phillips, Myles W Smith

Abstract read
In one paragraph

Article in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Symmetry-Driven Total Synthesis of Myrioneurinol.Journal of the American Chemical Society · 2022
    Article
  9. Review
  10. Marine Pyrrole Alkaloids.Marine drugs · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhen ZhangDepartment of Biochemistry, UT Southwestern Medical Center 5323 Harry Hines Blvd Dallas TX 75390 USA myles.smith@utsouthwestern.edu.ORCID https://orcid.org/0000-0001-9866-4523
Sneha RayDepartment of Biochemistry, UT Southwestern Medical Center 5323 Harry Hines Blvd Dallas TX 75390 USA myles.smith@utsouthwestern.edu.ORCID https://orcid.org/0000-0001-6649-956X
Leah ImlayDepartment of Biochemistry, UT Southwestern Medical Center 5323 Harry Hines Blvd Dallas TX 75390 USA myles.smith@utsouthwestern.edu.
Lauren T CallaghanDepartment of Biochemistry, UT Southwestern Medical Center 5323 Harry Hines Blvd Dallas TX 75390 USA myles.smith@utsouthwestern.edu.
Hanspeter NiederstrasserDepartment of Biochemistry, UT Southwestern Medical Center 5323 Harry Hines Blvd Dallas TX 75390 USA myles.smith@utsouthwestern.edu.
Prema Latha MallipeddiDepartment of Biochemistry, UT Southwestern Medical Center 5323 Harry Hines Blvd Dallas TX 75390 USA myles.smith@utsouthwestern.edu.
Bruce A PosnerDepartment of Biochemistry, UT Southwestern Medical Center 5323 Harry Hines Blvd Dallas TX 75390 USA myles.smith@utsouthwestern.edu.
Dawn M WetzelDepartment of Biochemistry, UT Southwestern Medical Center 5323 Harry Hines Blvd Dallas TX 75390 USA myles.smith@utsouthwestern.edu.ORCID https://orcid.org/0000-0002-3990-7043
Margaret A PhillipsDepartment of Biochemistry, UT Southwestern Medical Center 5323 Harry Hines Blvd Dallas TX 75390 USA myles.smith@utsouthwestern.edu.ORCID https://orcid.org/0000-0001-5250-5578
Myles W SmithDepartment of Biochemistry, UT Southwestern Medical Center 5323 Harry Hines Blvd Dallas TX 75390 USA myles.smith@utsouthwestern.edu.ORCID https://orcid.org/0000-0002-0231-0059

Funding

Targeting a New Therapy for TrypanosomatidsR01AI146349 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI WETZEL, DAWN MARIE · 2019 to 2023
$3.0M
Targeting malarial dihydroorotate dehydrogenaseR01AI053680 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI PHILLIPS, MARGARET A. · 2004 to 2008
$1.7M
An acoustic droplet ejection liquid dipenser for our UTSW HTS CoreS10OD026758 · OD · UT SOUTHWESTERN MEDICAL CENTER · PI POSNER, BRUCE ARTHUR · 2019 to 2019
$337k
NIAID NIH HHS R01 AI053680NIAID NIH HHS R01 AI146349NIH HHS S10 OD026758
6 · The paper itself

Abstract

The spiroindimicins are a unique class of chlorinated indole alkaloids characterized by three heteroaromatic rings structured around a congested spirocyclic stereocenter. Here, we report the first total synthesis of (+)-spiroindimicin A, which bears a challenging C-3'/C-5''-linked spiroindolenine. We detail our initial efforts to effect a biomimetic oxidative spirocyclization from its proposed natural precursor, lynamicin D, and describe how these studies shaped our final abiotic 9-step solution to this complex alkaloid built around a key Pd-catalyzed asymmetric spirocyclization. Scalable access to spiroindimicins A, H, and their congeners has enabled discovery of their activity against several parasites relevant to human health, providing potential starting points for new therapeutics for the neglected tropical diseases leishmaniasis and African sleeping sickness.

Identifiers

PMID34377425
PMCPMC8336461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.